Health Condition 1: M170- Bilateral primary osteoarthritis of knee Health Condition 2: M17- Osteoarthritis of knee Health Condition 3: M171- Unilateral primary osteoarthritisof knee
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects aged between 40 - 60 years. 2.Patients with classical presentations of Sandhigata vata and rajonivrutta stri will be selected irrespective of their religion and occupation. 3.Subjects fulfilling the diagnostic criteria & diagnosed previously (As per American college of Rheumatology (ACR) classification criteria for OA of the Knee). 4.Affected knee joint - Single or Both 5.Subject who submit a written informed consent. 6.One month after the completion of participation in any other clinical trial
Exclusion criteria
Exclusion criteria: 1.Severe arthritis1.(KL grade IV) 2.Patients with RA, Gout, Osteoporosis and other musculoskeletal system disorders 3.Known cases of secondary OA due to tuberculosis (TB), syphilis, aids and leprosy 4.Gross disability like bedridden and confined to wheel chair 5.Patients with other major systematic disorders which interfere with the treatment will be excluded like uncontrolled DM 6.Patients with .Significant knee injury within past 6 months; presence of a rash or open 6.wound over the knee. 7.Use of NSAID’s, Analgesics, Intra articular steroid injections within the past period of 30 days 8.Patients with history of knee surgery or arthroscopy within the past year; knee replacement on study knee 9.Any other conditions which in the opinion of investigator will place the subject at risk or will influence the conduct of study or interpretation of results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in Janu sandhi shoola (Knee osteoarthritic pain) i.e WOMAC28 (Western Ontario and Mc-Master University Osteoarthritis Index) and VAS29 ScaleTimepoint: baseline and at 30th ,60th days | — |
Secondary
| Measure | Time frame |
|---|---|
| –Changes on walking speed –Changes in Serum Calcium & alkaline phosphatase –Changes in inflammatory markers (IL 6 & TNF alpha) –Changes in Range of Motion : Goniometric assessment –Changes in Quality of Life (QoL): Short Form-36Timepoint: –from baseline & at 30th ,60th days – from baseline & in 60 days –from baseline & in 60th days –at baseline & at 30th, 60th days – at baseline & at 30th, 60th days | — |
Countries
India
Contacts
KAHERs Shri B M K Ayurveda Mahavidyalaya Shahapur Belagavi